Recruiting
Phase 2

AMPA Receptor Blockade

Sponsor:

Yale University

Code:

NCT05786066

Conditions

Depressive Disorder

Major Depressive Disorder

Bipolar Disorder

Post Traumatic Stress Disorder

Suicidal Ideation

Eligibility Criteria

Sex: All

Age: 21 - 65

Healthy Volunteers: Not accepted

Interventions

Perampanel 6 MG

Ketamine

Placebo

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2026-08-26. This information was provided to ClinicalTrials.gov by Yale University on 2026-05-06.